SA
GNNSF

S&P 500, Nasdaq, Russell 2000 below the 200-day average (VIX 24.9)

Overview →

Genscript Biotech Corporation (GNNSF)

Operating Expenses

$260.08M

TTM · Period ending: · USD

GNNSF logo

GNNSF Operating Expenses

Latest reported$260.08M
GNNSF Operating Expenses ($30.44M → $260.08M)
High-resolution chart · PNG

What is operating expenses?

Expenses from normal business operations (SG&A, R&D, etc.).

GNNSF operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Genscript Biotech Corporation Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
298,398,765
262,843,000
825,344,000
742,059,000
651,730,000
460,439,000
303,670,000
149,831,000
60,730,000
49,804,000
45,666,000
35,817,000
30,436,000

Frequently asked questions: GNNSF operating expenses

What is Genscript Biotech Corporation (GNNSF)'s current operating expenses?

Genscript Biotech Corporation (GNNSF)'s latest reported operating expenses (TTM) is $260.08M as of Jun 30, 2026. Expenses from normal business operations (SG&A, R&D, etc.).

How much historical operating expenses data is available for GNNSF?

Stock Alarm Pro provides 13 dated annual fiscal periods observations for Genscript Biotech Corporation (GNNSF)'s operating expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare GNNSF's operating expenses to peers or set an alert?

You can open GNNSF's operating expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on GNNSF delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.